glp-1 vomiting lawsuit in kentucky RA - Shreveport Lawyer glp-1 nausea class action in

Hims & Hers raised its full-year 2026 revenue guidance to a range of $2.8 billion to $3 billion, representing growth of 19% to 28% from 2025 levels, and updated adjusted EBITDA guidance to a range of $275 million to $350 million.

Behav Brain Res (2019) 370:111932

Because GLP-1 medications influence digestion, appetite, and metabolism, alcohol may feel different than it did before starting treatment

While further research is still needed to understand the connection between GLP-1 medications and reduced food noise, the following processes likely come into play

When prescribed and monitored by a qualified healthcare provider, these medications can: Improve insulin sensitivity Reduce appetite and food cravings Support weight loss in certain patients However, outside of a controlled medical environmen t, these effects can become unpredictable and even dangerous

Rathi A et al